*  US9029598B2 - Methods for production of arginine biocarbonate at low pressure - Google Patents
Halogenated aminohexanoates and aminobutyrates antimicrobial agents US5370865A (en) 1992-05-15. 1994-12-06. Kao Corporation. ... Halogenated aminohexanoates and aminobutyrates antimicrobial agents US5286480A (en) 1992-06-29. 1994-02-15. The Procter & ...
*  Structure of PTT and the reaction catalyzed by HEPDThe | Open-i
Structure of PTT and the reaction catalyzed by HEPDThe biosyntheses of the commercial herbicide phosphinothricin (boxed in the PTT structure) and the clinically
*  Susan S Girdler - Publications - University of North Carolina at Chapel Hill
Gordon, J. L., Girdler, S. S., Meltzer-Brody, S. E., Stika, C. S., Thurston, R. C., Clark, C. T., Prairie, B. A., Moses-Kolko, E., Joffe, H. & Wisner, K. L. Mar 1 2015 In : American Journal of Psychiatry. 172, 3, p. 227-236 10 p.. Research output: Contribution to journal › Review article ...
*  Progabide - DrugBank
Progabide is an analog and prodrug of gamma-aminobutyric acid. It is commonly used in the treatment of epilepsy. It has agonistic activity for both the GABAA and GABAB receptors. Progabide has been investigated for many diseases besides epilepsy, including Parkinson's disease, schizophrenia, clinical depression and anxiety disorder with varying success.
*  "A Comparison of Reversible Versus Irreversible Protein Glutathionylati" by Danyelle M. Townsend, Volodymyr I. Lushchak et al.
Glutathionylation is generally a reversible posttranslational modification that occurs to cysteine residues that have been exposed to reactive oxygen species (P-SSG). This cyclical process can regulate various clusters of proteins, including those involved in critical cellular signaling functions. However, certain conditions can favor the formation of dehydroamino acids, such as 2,3-didehydroalanine (2,3-dehydroalanine, DHA) and 2,3-didehydrobutyrine (2,3-dehydrobutyrine), which can act as Michael acceptors. In turn, these can form Michael adducts with glutathione (GSH), resulting in the formation of a stable thioether conjugate, an irreversible process referred to as nonreducible glutathionylation. This is predicted to be prevalent in nature, particularly in more slowly turning over proteins. Such nonreducible glutathionylation can be distinguished from the more facile cycling signaling processes and is predicted to be of gerontological, toxicological, pharmacological, and oncological relevance. Here,